InnovAge Holding Correlations
INNV Stock | USD 4.80 0.03 0.63% |
The current 90-days correlation between InnovAge Holding Corp and Enhabit is 0.25 (i.e., Modest diversification). The correlation of InnovAge Holding is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
InnovAge Holding Correlation With Market
Very weak diversification
The correlation between InnovAge Holding Corp and DJI is 0.47 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding InnovAge Holding Corp and DJI in the same portfolio, assuming nothing else is changed.
InnovAge |
Moving together with InnovAge Stock
0.73 | EKSO | Ekso Bionics Holdings | PairCorr |
0.67 | MDT | Medtronic PLC | PairCorr |
0.73 | LIFWW | MSP Recovery | PairCorr |
0.64 | KIDS | Orthopediatrics Corp | PairCorr |
Moving against InnovAge Stock
0.78 | ELMD | Electromed | PairCorr |
0.65 | VREX | Varex Imaging Corp | PairCorr |
0.63 | OM | Outset Medical | PairCorr |
0.62 | DOCS | Doximity Sell-off Trend | PairCorr |
0.6 | DXCM | DexCom Inc | PairCorr |
0.56 | GH | Guardant Health | PairCorr |
0.48 | MD | Mednax Inc | PairCorr |
0.37 | VNRX | Volitionrx | PairCorr |
0.36 | LH | Laboratory | PairCorr |
0.34 | EW | Edwards Lifesciences Corp | PairCorr |
0.72 | BSX | Boston Scientific Corp | PairCorr |
0.69 | PODD | Insulet | PairCorr |
0.64 | NPCE | Neuropace | PairCorr |
0.63 | LNSR | LENSAR Inc | PairCorr |
0.6 | SYK | Stryker | PairCorr |
0.58 | MMSI | Merit Medical Systems | PairCorr |
0.53 | WGS | GeneDx Holdings Corp | PairCorr |
0.51 | FNA | Paragon 28 | PairCorr |
0.38 | OFIX | Orthofix Medical | PairCorr |
0.76 | TCMD | Tactile Systems Tech | PairCorr |
0.46 | DMAC | DiaMedica Therapeutics | PairCorr |
0.45 | CVRX | CVRx Inc Fiscal Year End 23rd of January 2025 | PairCorr |
0.39 | BWAY | Brainsway | PairCorr |
0.34 | AORT | Artivion | PairCorr |
0.33 | VANI | Vivani Medical | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between InnovAge Stock performing well and InnovAge Holding Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze InnovAge Holding's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ENSG | 1.05 | 0.01 | 0.00 | 0.07 | 0.00 | 2.32 | 10.08 | |||
SEM | 1.55 | (0.04) | 0.00 | 0.09 | 1.92 | 2.91 | 14.62 | |||
EHC | 0.91 | 0.14 | 0.06 | 0.50 | 0.84 | 1.74 | 9.75 | |||
EHAB | 1.84 | (0.26) | 0.00 | (0.09) | 0.00 | 5.22 | 11.79 | |||
PNTG | 2.16 | (0.29) | 0.00 | (0.08) | 0.00 | 4.12 | 12.42 | |||
NHC | 1.50 | (0.27) | 0.00 | (0.04) | 0.00 | 3.12 | 11.56 | |||
MODV | 4.53 | (0.11) | 0.00 | (0.36) | 0.00 | 7.43 | 65.08 | |||
CCEL | 3.25 | 0.62 | 0.19 | 3.65 | 2.47 | 7.14 | 30.49 |
InnovAge Holding Corporate Management
Maria Lozzano | Chief Officer | Profile | |
Robin Doerr | Chief Officer | Profile | |
JD Kennedy | Independent Director | Profile | |
Cara Babachicos | Chief Officer | Profile | |
RN MHA | Independent Director | Profile |